4.3 Article

Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay

Fabricio F. T. Barros et al.

BREAST CANCER RESEARCH AND TREATMENT (2014)

Article Pathology

A novel model for Ki67 assessment in breast cancer

Quinci Romero et al.

DIAGNOSTIC PATHOLOGY (2014)

Article Medicine, Research & Experimental

Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer

Jason R. Brown et al.

LABORATORY INVESTIGATION (2014)

Article Medicine, Research & Experimental

Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue

Steven J. Potts et al.

LABORATORY INVESTIGATION (2012)

Article Multidisciplinary Sciences

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Dana Faratian et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)

Article Oncology

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Maggie C. U. Cheang et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Article Oncology

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma

Emad A. Rakha et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)